ReviewStem cell reviews and reports2024

Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches.

Vahid Mohammadi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.